New Products
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24017 | AMG-193 | 2790567-82-5 | 98.62%; EE 98.28% |  |
| AMG-193是安进公司开发的一种口服小分子甲硫腺苷协同PRMT5酶抑制剂 | ||||
| 20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% |  |
| ATH434 是一种口服药物，旨在抑制与神经变性有关的病理蛋白的聚 | ||||
| 20633 | STX-478 | 2883540-92-7 | ≧98.0% |  |
| STX-478 是第二代突变体选择性口服 PI3Ka 小分子变构抑制剂。 | ||||
| 24084 | Iclepertin (BI-425809) | 1421936-85-7 | ≧98.0% | _1421936-85-7.png) |
| Iclepertin（BI-425809）是一种口服的GlyT-1小分子抑制剂，用于治疗与 | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib（之前称为 INCB 00928）是一种激活素受体样激酶 2（ALK2， | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 23122601 | Navacaprant | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿 | ||||
| 171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% | .png) |
| Bexotegrast（同义词：PLN-74809）是一种小分子、双重选择性 αVβ1 / α | ||||
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% | _2093305-05-4.png) |
| Fosgonimeton (ATH-1017) 是一种小分子，旨在增强肝细胞生长因子 (HGF) | ||||
| 52013 | ONX-0914 ( PR-957 ) | 960374-59-8 | ≧95.0% |  |
| ONX-0914 是免疫蛋白酶体 LMP7 和 LMP2 亚基的抑制剂，在多种自身免疫 | ||||
| 24067 | PBT434 氢溴酸盐 | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||